References

1.   Foley P, Freeman M, Siller G, Gebauer K, Murrell D, Barnetson R, et al. A phase III randomized study comparing photodynamic therapy (PDT) using methyl aminolevulinate or placebo cream in nodular basal cell carcinoma (NBCC). J Eur Acad Dermatol Venereol 2003; 17 (Suppl 3):231

2.   Juzeniene A, Juzenas P, Ma LW, Iani V, Moan J. Effectiveness of different light sources for 5-aminolevulinic acid photodynamic therapy. Lasers Med Sci 2004; 19: 139-149.
 
3.   Brown SB. The role of light in the treatment of non-melanoma skin cancer using methyl aminolevulinate. J Dermatol Treat 2003; 14 (Suppl 3): 11-14.

4.   Morton CA. Methyl aminolevulinate (Metvix®) photodynamic therapy - practical pearls. J Dermatolog Treat 2003; 14 (Suppl 3): 23-26.

5.   Metvix® European SmPC.

6.   Freeman M, Vinciullo C, Francis D et al. A comparison of photodynamic therapy using topical methyl aminolevulinate (Metvix®) with single cycle cryotherapy in patients with actinic keratosis: a prospective, randomized study. J Dermatol Treat 2003; 14: 99-106.

7.   Gardlo K and Ruzicka T. Metvix® PhotoCure. Curr Op Invest Drugs 2002; 3: 1672-1678.

8.   Horn M, Wolf P, Wulf HC, Warloe T, Fritsch C, Rhodes LE, et al. Topical methyl aminolaevulinate photodynamic therapy in patients with basal cell carcinoma prone to complications and poor cosmetic outcome with conventional therapy. Br J Dermatol 2003;149:1242-9.
 
9.   Szeimies RM, Karrer S, Radakovic-Fijan S et al. Photodynamic therapy using topical methyl 5-aminolevulinate compared with cryotherapy for actinic keratosis: A prospective, randomized study. J Am Acad Dermatol 2002; 47: 258-262.

10.   Rhodes LE, de Rie M, Enström Y et al. Photodynamic therapy using topical methyl aminolevulinate vs surgery for nodular basal cell carcinoma. Results of a multicenter randomized prospective trial. Arch Dermatol 2004; 140: 17-23.

11.   Pariser DM, Lowe NJ, Stewart DM et al. Photodynamic therapy with topical methyl aminolevulinate for actinic keratosis: results of a prospective randomized multicenter trial. J Am Acad Dermatol 2003; 48: 227-232.

12. Szeimies RM, Karrer S, Radakovic-Fijan S, Tanew A, Calzavara-Pinton PG, Zane C, et al. Photodynamic therapy using topical methyl 5-aminolevulinate compared with cryotherapy for actinic keratosis: A prospective, randomized study. J Am Acad Dermatol 2002; 47: 258-62.

13.   Foley P, Pariser D, Tarstedt M, Tope WD, Vinciullo C. Patient satisfaction after treatment with MAL-PDT of basal Cell carcinoma and actinic keratoses with MAL-PDT compared to previous other therapies. J Eur Acad Dermatol Venereol 2005;19 (Suppl 2):240.

14.   Morton C, Horn M, Leman J, Tack B, Bedane C, Tjioe M, et al. Comparison of topical methyl aminolevulinate photodynamic therapy with cryotherapy or fluorouracil for treatment of squamous cell carcinoma in situ: Results of a multicenter randomized trial. Arch Dermatol 2006;142:729-35.

15.   Tarstedt M, Rosdahl I, Berne B, Svanberg K, Wennberg AM. A randomized multicenter study to compare two treatment regimens of topical methyl aminolevulinate (Metvix®)-PDT in actinic keratosis of the face and scalp. Acta Derm Venereol 2005;85:424-8.

16.   Soler AM, Warloe T, Berner A, Giercksky KE. A follow-up study of recurrence and cosmesis in completely responding superficial and nodular basal cell carcinomas treated with methyl 5-aminolaevulinate-based photodynamic therapy alone and with prior curettage. Br J Dermatol 2001;145:467-71.

17.   Vinciullo C, Elliott T, Francis D, Gebauer K, et al. Photodynamic therapy with topical methyl aminolaevulinate for 'difficult-to-treat' basal cell carcinoma. Br J Dermatol 2005; 152: 765-772.

18.  Basset-Seguin, Ibbotson S, Emtestam L, Tarstedt M. Photodynamic Therapy Using Methyl Aminolevulinate is as efficacious as cryotherapy in BCC, with better cosmetic results. Poster Abstract Book Am Acad Dermatol 2003; P505: 180. http://www.aad.org/professionals/MeetingsEvents/posterabstracts.htm (by clicking on this link you will be leaving this site - Galderma is not responsible for the content)
 
19.   Basset-Seguin N, Ibbotson S, Emtestam L, Tarstedt M, Morton C, Maroti M, et al. MAL-PDT vs. cryotherapy in primary sBCC: results of 36-month follow up. J Eur Acad Dermatol Venereol 2004;18 (Suppl 2):412.

20.   Dragieva G, Prinz BM, Hafner J, Dummer R, Burg G, Binswanger U, Kempf W. A randomized controlled clinical trial of topical photodynamic therapy with methyl aminolaevulinate in the treatment of actinic keratoses in transplant recipients. Br J of Dermatol 2004; 151: 196-200.

21.   Tope WD, Menter A, El-Azhary RA, Lowe NJ, Jarratt M, Rich P, Pariser DM, et al.  A comparison of topical MAL-PDT vs. placebo-PDT in nodular basal cell carcinoma: results of a North American study. J Eur Acad Dermatol Venereol 2004;18 (Suppl 2):413-414.

22.  Interventional Procedure Guidance 155:  Photodynamic therapy for non-melanoma skin tumours (including premalignant and primary non-metastatic skin lesions).  NHS, National Institute for Health and Clinical Excellence, 2006, London, UK.